SalvaRx Group PLC (LSE:SALV) - Share price - Overview

Stock Report

SalvaRx Group PLC SALV

Last Price
GBX33.63

Day Change
-0.38|-1.10%

As of 27/02/2017
08:41:57 GMT | GBX
Minimum 15 Minutes Delay.

Last Close34.00p
Day Range33.63 - 33.63
Mkt Cap12.40Mil
52-Wk Range22.25 - 41.25
Yield %0.00
ISINIM00BZ4SS228
Volume3,242
P/E-8.41
P/SInfinity
P/CF-5.69

Share Price

Total Returns 24/02/2017

 Chg (%)  
More ...
SalvaRx Group PLC19.30 
FTSE 100 TR GBP2.08
 
Financials
201320142015
More ...
Income Statement
Turnover0.000.000.00
Operating Profit0.000.00-0.19
Net Profit0.000.00-0.19
Reported EPS0.000.00-4.00
Balance Sheet
Current Assets27.121.441.00
Non Current Assets25.870.000.22
Total Assets52.991.441.22
Current Liabilities0.420.140.12
Total Liabilities0.420.140.12
Total Equity52.561.291.10
Cash Flow
Operating Cash Flow-2.78-1.49-0.30
Net Change in Cash-12.53-25.42-0.43
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

SalvaRx Group PLC is a drug discovery and development company focused on immune-oncology. It invests in cancer immuno-therapies and provides its portfolio companies with operational support.

Sector

Biotechnology

Market Position

1473 of 1853 Companies

Index

FTSE AIM All Share

Outlook

(13/09/2016) no outlook statement

Next Event 27/06/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0014.3416.13
Div Yld (E)0.003.764.10
PEG (E)0.00-0.431.08
ROCE-17.52202.62104.73
Op Mrgn0.00-9.81-16.30
EPS Grwth0.0043.0235.18
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanJim Mellon
Chief Executive OfficerDr. Ian Walters
Chief Financial OfficerKam Shah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.